A preclinical study published in the Journal of Alzheimer’s Disease found that very small doses of tetrahydrocannabinol (THC), can slow the production of toxic clumps of beta-amyloid proteins in the brain, which are thought to kick start the progression of Alzheimer’s disease.

In a healthy brain, these...

Cannabis has always been expensive to buy off the black market, we pay the grower a premium for taking the risk of possibly going to jail, then it goes through the various middle men, who take their cut, till eventually we get to the street value, taking into account all the risks of possible prosecution.

GW Pharmaceuticals has chosen the perfect moment to file its cannabis-derived therapy, Epidiolex, with U.S. regulators.

The New England Journal of Medicine just published results from a Phase III study showing that GW’s Epidiolex (derived from cannabidiol) significantly reduced monthly convulsive seizures, especially in children...